MCELHAUGH MICHAEL J. (Chief Business Officer) received a stock award from ARBUTUS BIOPHARMA CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0001447028-25-000051
Officer· Chief Business Officer
Since Dec 2018
+895.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
895.80K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+177K
Price / share
—
Trade value
—
% of position
12.0%
2/14/2025
1.48M→1.66M
Total
Net shares
+177K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/14/2025 | A · Award | +177K | — | — | 12.0% | 1.48M | 1.66M |
| Total | +177K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
718.80K shares
Shares
+718.80K
Strike price
3.29
Held after
718.80K
Exercisable
—
2/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares718.80K shares | 2/14/2025 | A · Award | +718.80K | 3.29 | — | 718.80K |